Establishment of a rapid Bordetella pertussis detection method based on RPA-CRISPR-Cas12a technology
Archives of Microbiology · 2025
DOI: 10.1007/s00203-025-04438-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Microbiology, 2025. Verfasst von Wenxiang Ji und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, the First Affiliated Hospital of Anhui Medical University, Hefei, 230022, People's Republic of China. Hauptthemen laut MEDLINE: Bordetella pertussis, Whooping Cough, CRISPR-Cas Systems, Nucleic Acid Amplification Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Anhui Institute of Translational Medicine, the Youth Science Foundation of Anhui Medical University, he Key Project of Natural Science in Colleges and Universities of Anhui Province.
Abstract (Originalsprache)
Whooping cough (pertussis) is an acute respiratory infectious disease caused by Bordetella pertussis (BP). It poses a risk to infants and young children. This investigation aimed to construct a simple, rapid, and accurate diagnostic protocol for BP detection that does not depend on complex equipment or large-scale instruments. This study combines Recombinase Polymerase Amplification (RPA) technology with the CRISPR/Cas12a system, utilizing immunochromatographic lateral flow strips (ILFS) test and fluorescence curves to observe data. This diagnostic strategy does not require complex equipment used in traditional diagnostic approaches (such as bacterial culture, pathogen detection, and molecular biology techniques), which has increased its accessibility and ease of use. The validation data indicate that the RPA-CRISPR/Cas12a-ILFS and RPA-CRISPR/Cas12a fluorescence detection analyses had a lower detection threshold of 102 copies/µL and did not cross-react with other prevalent infections. Furthermore, 40 clinical samples were evaluated and compared via qPCR, which revealed that the RPA-CRISPR/Cas12a method has 100% sensitivity and specificity. In addition, the RPA-CRISPR/Cas12a diagnostic platform showed significant potential for clinical application, specifically when resources are limited, enabling point-of-care testing. This platform's simplicity, accuracy, and efficiency make it a powerful tool for pertussis diagnosis, which can improve patient care and public health outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, the First Affiliated Hospital of Anhui Medical University, Hefei, 230022, People's Republic of China.
- Department of Clinical Laboratory, Anhui Public Health Clinical Center, Hefei, 230012, People's Republic of China.
- Department of Clinical Laboratory, the First Affiliated Hospital of Anhui Medical University, Hefei, 230022, People's Republic of China. shenjilu@ahmu.edu.cn.
- Department of Clinical Laboratory, Anhui Public Health Clinical Center, Hefei, 230012, People's Republic of China. shenjilu@ahmu.edu.cn.
Förderung
- Anhui Institute of Translational Medicine
- the Youth Science Foundation of Anhui Medical University
- he Key Project of Natural Science in Colleges and Universities of Anhui Province
Zitieren
APA
Ji, W., Yuan, L., Hu, T., Jiang, M., & Shen, J. (2025). Establishment of a rapid Bordetella pertussis detection method based on RPA-CRISPR-Cas12a technology. Archives of Microbiology. https://doi.org/10.1007/s00203-025-04438-5
Vancouver
Ji W, Yuan L, Hu T, Jiang M, Shen J. Establishment of a rapid Bordetella pertussis detection method based on RPA-CRISPR-Cas12a technology. Archives of Microbiology. 2025. doi:10.1007/s00203-025-04438-5
BibTeX
@article{Ji2025,
author = {Ji, Wenxiang and Yuan, Lufei and Hu, Tingting and Jiang, Min and Shen, Jilu},
title = {Establishment of a rapid Bordetella pertussis detection method based on RPA-CRISPR-Cas12a technology},
journal = {Archives of Microbiology},
year = {2025},
doi = {10.1007/s00203-025-04438-5}
}
EUVIMED